Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Corcept Therapeutics (CORT) over the last 13 years, with Q3 2025 value amounting to $289000.0.

  • Corcept Therapeutics' Depreciation & Amortization (CF) fell 911.95% to $289000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 5673.08%. This contributed to the annual value of $795000.0 for FY2024, which is 2370.44% down from last year.
  • According to the latest figures from Q3 2025, Corcept Therapeutics' Depreciation & Amortization (CF) is $289000.0, which was down 911.95% from $286000.0 recorded in Q2 2025.
  • Corcept Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $2.2 million for Q2 2021, and its period low was -$1.7 million during Q3 2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $264631.6, with a median of $281000.0 in 2024.
  • Examining YoY changes over the last 5 years, Corcept Therapeutics' Depreciation & Amortization (CF) showed a top increase of 168790.32% in 2021 and a maximum decrease of 208588.24% in 2021.
  • Over the past 5 years, Corcept Therapeutics' Depreciation & Amortization (CF) (Quarter) stood at $289000.0 in 2021, then skyrocketed by 128.37% to $660000.0 in 2022, then plummeted by 67.58% to $214000.0 in 2023, then skyrocketed by 31.31% to $281000.0 in 2024, then rose by 2.85% to $289000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $289000.0 in Q3 2025, compared to $286000.0 in Q2 2025 and $285000.0 in Q1 2025.